AAAAAA

   
Results: 1-9 |
Results: 9
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
Authors: Charlton, M Kasparova, P Weston, S Lindor, K Maor-Kendler, Y Wiesner, RH Rosen, CB Batts, KP
Citation: M. Charlton et al., Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease, LIVER TRANS, 7(7), 2001, pp. 608-614
Recurrent autoimmune hepatitis after orthotopic liver transplantation
Authors: Gonzalez-Koch, A Czaja, AJ Carpenter, HA Roberts, SK Charlton, MR Porayko, MK Rosen, CB Wiesner, RH
Citation: A. Gonzalez-koch et al., Recurrent autoimmune hepatitis after orthotopic liver transplantation, LIVER TRANS, 7(4), 2001, pp. 302-310
Graft survival in pediatric liver transplantation
Authors: Langham, MR Tzakis, AG Gonzalez-Peralta, R Thompson, JF Rosen, CB Nery, JR Reed, AI Ruiz, P VanderWerf, WJ Hemming, A Howard, RJ
Citation: Mr. Langham et al., Graft survival in pediatric liver transplantation, J PED SURG, 36(8), 2001, pp. 1205-1209
Pulmonary hemodynamics and perioperative cardiopulmonary-related mortalityin patients with portopulmonary hypertension undergoing liver transplantation
Authors: Krowka, MJ Plevak, DJ Findlay, JY Rosen, CB Wiesner, RH Krom, RAF
Citation: Mj. Krowka et al., Pulmonary hemodynamics and perioperative cardiopulmonary-related mortalityin patients with portopulmonary hypertension undergoing liver transplantation, LIVER TRANS, 6(4), 2000, pp. 443-450
Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma
Authors: De Vreede, I Steers, JL Burch, PA Rosen, CB Gunderson, LL Haddock, MG Burgart, L Gores, GJ
Citation: I. De Vreede et al., Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma, LIVER TRANS, 6(3), 2000, pp. 309-316
Infusion of donor spleen cells and rejection in liver transplant recipients
Authors: Scornik, JC Lauwers, GY Reed, AI Howard, RJ Dickson, RC Rosen, CB
Citation: Jc. Scornik et al., Infusion of donor spleen cells and rejection in liver transplant recipients, CLIN TRANSP, 14(1), 2000, pp. 55-60
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases
Authors: Maor-Kendler, Y Batts, KP Burgart, LJ Wiesner, RH Krom, RA Rosen, CB Charlton, MR
Citation: Y. Maor-kendler et al., Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases, TRANSPLANT, 70(2), 2000, pp. 292-297
Long-term results of patients undergoing liver transplantation for primarysclerosing cholangitis
Authors: Graziadei, IW Wiesner, RH Marotta, PJ Porayko, MK Hay, JE Charlton, MR Poterucha, JJ Rosen, CB Gores, GY LaRusso, NF Krom, RAF
Citation: Iw. Graziadei et al., Long-term results of patients undergoing liver transplantation for primarysclerosing cholangitis, HEPATOLOGY, 30(5), 1999, pp. 1121-1127
The utility of noninvasive serologic markers in the management of early allograft rejection in liver transplantation recipients
Authors: Dickson, RC Lauwers, GY Rosen, CB Cantwell, R Nelson, DR Lau, JYN
Citation: Rc. Dickson et al., The utility of noninvasive serologic markers in the management of early allograft rejection in liver transplantation recipients, TRANSPLANT, 68(2), 1999, pp. 247-253
Risultati: 1-9 |